HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,937,120 | -3.3% | 155,422 | -8.7% | 0.07% | +4.3% |
| Q2 2023 | $6,139,042 | -14.6% | 170,198 | -9.6% | 0.07% | -17.6% |
| Q1 2023 | $7,186,747 | -34.9% | 188,184 | -3.1% | 0.08% | -38.4% |
| Q4 2022 | $11,045,997 | +45.1% | 194,130 | +0.8% | 0.14% | +34.0% |
| Q3 2022 | $7,615,000 | -15.5% | 192,599 | -5.9% | 0.10% | -10.4% |
| Q2 2022 | $9,009,000 | +76.0% | 204,745 | +59.5% | 0.12% | +113.0% |
| Q1 2022 | $5,120,000 | +1.1% | 128,384 | +1.9% | 0.05% | +5.9% |
| Q4 2021 | $5,064,000 | -0.6% | 125,933 | +0.5% | 0.05% | 0.0% |
| Q3 2021 | $5,097,000 | -5.5% | 125,300 | +5.5% | 0.05% | -3.8% |
| Q2 2021 | $5,393,000 | +12.8% | 118,762 | +3.5% | 0.05% | +6.0% |
| Q1 2021 | $4,783,000 | -5.8% | 114,721 | -3.5% | 0.05% | -13.8% |
| Q4 2020 | $5,079,000 | – | 118,927 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |